Education
About Us
Working with TipRanks
Follow Us
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.80M | $ 38.91M | $ 26.00M | $ 110.78M | $ 85.08M |
| Gross Profit | $ 2.80M | $ 38.91M | $ 26.00M | $ 108.74M | $ 85.08M |
| Operating Income | $ -86.70M | $ -43.90M | $ -86.42M | $ 14.54M | $ -4.60M |
| EBITDA | $ -86.70M | $ -75.99M | $ -235.03M | $ 39.84M | $ -5.16M |
| Net Income | $ -130.30M | $ -77.42M | $ -219.71M | $ 35.38M | $ -25.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 125.14M | $ 212.61M | $ 76.91M | $ 134.60M | $ 128.06M |
| Total Assets | $ 296.41M | $ 435.02M | $ 305.05M | $ 165.89M | $ 159.88M |
| Total Debt | $ 12.68M | $ 13.98M | $ 10.96M | $ 37.92M | $ 35.28M |
| Net Debt | $ -112.46M | $ -198.63M | $ -65.96M | $ -68.51M | $ -78.78M |
| Total Liabilities | $ 422.65M | $ 441.82M | $ 745.23M | $ 72.06M | $ 137.36M |
| Stockholders' Equity | $ -126.24M | $ -6.80M | $ -440.18M | $ 93.83M | $ 22.52M |
| Cash Flow | |||||
| Free Cash Flow | $ -79.39M | $ -32.77M | $ -51.37M | $ -32.83M | $ -61.47M |
| Operating Cash Flow | $ -73.94M | $ -23.67M | $ -51.16M | $ -31.63M | $ -60.38M |
| Investing Cash Flow | $ -5.45M | $ -8.74M | $ 34.61M | $ -15.00M | $ -17.14M |
| Financing Cash Flow | $ -8.05M | $ 168.43M | $ -13.14M | $ 39.22M | $ 52.90M |